Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Establishes $400M Loan Facility for Caliper Purchase

NEW YORK (GenomeWeb News) – PerkinElmer has entered into a commitment letter for a 364-day bridge loan facility for up to $400 million to fund its proposed purchase of Caliper Life Sciences, it disclosed this week in a document filed with the US Securities and Exchange Commission.

The firm said it entered into a commitment letter on Sept. 7 with Bank of America and Merrill Lynch, Pierce, Fenner & Smith for the loan facility. Bank of America will act as an initial lender and administrative agent, while Merrill Lynch will be the lead arranger and book-running manager.

In addition to helping fund PerkinElmer's $600 million proposed acquisition of Caliper, the loan facility will be used to refinance certain of both firms' debt, and to pay fees and expenses incurred in connection with the transactions.

In connection with the loan facility, PerkinElmer has agreed to engage an investment banker and "use commercially reasonable efforts" to issue up to $400 million of senior unsecured notes or other securities.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.